Preview

Complex Issues of Cardiovascular Diseases

Advanced search

RESULTS OF THE REGIONAL PROJECT “KUZBASS WITHOUT ARRHYTHMIA”

https://doi.org/10.17802/2306-1278-2026-15-1-174-179

Abstract

Highlights

  • For the first time in Kuzbass, a study was conducted to identify asymptomatic cardiac arrhythmias in the working-age population at the enterprise «AZOT». The study allowed for early diagnosis of arrhythmias requiring interventional treatment, reduced risks of complications, and ensured the return to work and a full life for patients with asymptomatic heart rhythm disorders.

 

Aim. To conduct a comprehensive examination to identify the prevalence of asymptomatic heart rhythm disorders requiring interventional treatment for tachyarrhythmia among the working-age population of AZOT LLC.

Methods. As part of the regional project «Kuzbass without arrhythmia» а total of 1,324 AZOT employees were examined, including 745 men (56.3%) and 578 women (43.7%), with an average age of 54 years. The first stage of the study included lectures on cardiovascular diseases for employees, while the second stage involved an assessment of their medical history and laboratory and instrumental examinations.

Results. The lecture course contributed to a 2.5–fold increase in employee motivation to complete the second stage of the examination. Atrial fibrillation and ventricular extrasystole (VES) were detected in 0.6% of ECG recordings and 0.4%, respectively. During 24-hour ECG monitoring, atrial fibrillation was detected in 1.8% of patients, ventricular extrasystoles in 4.8%, and supraventricular extrasystoles in 3.7%. Heart rhythm disturbances occurred in one in ten patients, with no symptoms or clinical manifestations, representing a 9.1% incidence. All patients with atrial fibrillation had indications for surgical treatment. Follow-up observation is recommended for supraventricular and ventricular extrasystoles.

Conclusion. Increased staff awareness facilitated the detection of arrhythmias and timely treatment.

About the Authors

Zakir Z. Khalimov
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

PhD, Doctor specializing in X-ray endovascular diagnostic and treatment methods, Junior Researcher at the Laboratory of Heart Rhythm Disorders and Electrocardiostimulation, Department of Heart and Vascular Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation



Sergey E. Mamchur
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

PhD, MD, Head of the Laboratory of Heart Rhythm Disorders and Electrocardiostimulation, Department of Heart and Vascular Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation



Elena V. Gorbunova
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

PhD, MD, Leading Researcher of the Laboratory of Heart Rhythm Disorders and Electrocardiostimulation, Department of Heart and Vascular Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation



Angelina N. Altymysheva
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation

Clinical Resident of the Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation



Tatyana A. Anichkova
Joint Stock Company Clinic Energetik
Russian Federation

General Director (Chief Physician) of the Joint Stock Company Clinic Energetik, Kemerovo, Russian Federation



Anastasia V. Kleshcheva
Joint Stock Company Clinic Energetik
Russian Federation

Therapeutist of the Joint Stock Company Clinic Energetik, Kemerovo, Russian Federation



References

1. Arnar DO, Mairesse GH, Boriani G, et al. ESC Scientific Document Group; EHRA Scientific Documents Committee. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace. 2019 Mar 18;21(6):844–845. doi: 10.1093/europace/euz046. 

2. Rho RW, Page RL. Asymptomatic atrial fibrillation. Prog Cardiovasc dis. 2005; 48(2): 79-87. doi: 10.1016/j.pcad.2005.06.005.

3. Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017; 40(6): 413-418. doi: 10.1002/clc.22667.

4. Boriani G, Valzania C, Biffi M, et al. Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia? Curr Pharm Des. 2015; 21(5): 659-666. doi: 10.2174/1381612820666140825142639.

5. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol. 2000; 4(2): 369-382. doi: 10.1023/a:1009823001707.

6. DePaula RS, Antelmi I, Vincenzi MA, et al. Cardiac arrhythmias and atrioventricular block in a cohort of asymptomatic individuals without heart disease. Cardiology. 2007;108(2):111-6. doi: 10.1159/000095950.

7. Bikkina M, Larson MG, Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med. 1992; 117(12): 990-996. doi: 10.7326/0003-4819-117-12-990.

8. Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015; 128(5): 509-518.e2. doi: 10.1016/j.amjmed.2014.11.026.

9. Flaker GC, Belew K, Beckman K, et al.; AFFIRM Investigators. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005; 149(4): 6. 57-63. doi: 10.1016/j.ahj.2004.06.032.

10. Rienstra M, Vermond RA, Crijns HJ, Tijssen JG, Van Gelder IC; RACE Investigators. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study. Heart Rhythm. 2014;11(6): 939-45. doi: 10.1016/j.hrthm.2014.03.0169.

11. Potpara TS, Polovina MM, Marinkovic JM, Lip GY. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2013; 168(5): 4744-4749. doi: 10.1016/j.ijcard.2013.07.234.


Review

For citations:


Khalimov Z.Z., Mamchur S.E., Gorbunova E.V., Altymysheva A.N., Anichkova T.A., Kleshcheva A.V. RESULTS OF THE REGIONAL PROJECT “KUZBASS WITHOUT ARRHYTHMIA”. Complex Issues of Cardiovascular Diseases. 2026;15(1):174-179. (In Russ.) https://doi.org/10.17802/2306-1278-2026-15-1-174-179

Views: 109

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)